Edwards PASCAL 경피적 판막 수리 시스템 Pivotal 임상 시험 (CLASP II TR)
삼첨판 역류가 있는 환자에서 OMT 단독 요법과 비교하여 Edwards PASCAL 경피적 경피적 판막 수리 시스템 및 최적의 의료 요법(OMT)을 사용한 경피적 삼첨판 치료의 안전성과 유효성을 평가하기 위한 전향적, 다기관, 무작위, 통제 중추 임상시험
To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
A Prospective, multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter tricuspid valve repair with the Edwards PASCAL Transcatheter Valve Repair System and optimal medical therapy (OMT) compared to OMT alone in patients with tricuspid regurgitation. Patients will be seen for follow-up visits at discharge, 30 days, 3 months, 6 months, and annually through 5 years.
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Arizona
-
Phoenix, Arizona, 미국, 85006
- Banner University Medical Center Phoenix
-
Tucson, Arizona, 미국, 85712
- Tucson Medical Center Healthcare
-
-
California
-
Irvine, California, 미국, 92868
- University of California, Irvine
-
La Jolla, California, 미국, 92037
- SCPMG - Kaiser San Diego
-
Los Angeles, California, 미국, 90048
- Cedars Sinai Medical Center
-
Los Angeles, California, 미국, 90095
- UCLA Medical Center
-
San Francisco, California, 미국, 94143
- University of California, San Francisco
-
San Francisco, California, 미국, 94118
- Kaiser Permanente San Francisco
-
Stanford, California, 미국, 94305
- Stanford University
-
-
Colorado
-
Denver, Colorado, 미국, 80218
- St. Joseph Hospital
-
Loveland, Colorado, 미국, 80538
- Medical Center of the Rockies
-
-
Florida
-
Gainesville, Florida, 미국, 32605
- The Cardiac and Vascular Institute Research Foundation
-
Miami Beach, Florida, 미국, 33140
- Mount Sinai Medical Center
-
Naples, Florida, 미국, 34102
- NCH Healthcare System
-
Sarasota, Florida, 미국, 34239
- Sarasota Memorial Health Care System
-
Tallahassee, Florida, 미국, 32308
- Tallahassee Research Institute
-
-
Georgia
-
Atlanta, Georgia, 미국, 30309
- Piedmont Healthcare, Inc.
-
Atlanta, Georgia, 미국, 30308
- Emory University Hospital Midtown / Emory University - St. Joseph's Hospital
-
-
Illinois
-
Chicago, Illinois, 미국, 60611
- Northwestern University
-
-
Indiana
-
Indianapolis, Indiana, 미국, 46290
- Ascension St. Vincent Heart Center Cardiovascular Research Institute
-
-
Iowa
-
Iowa City, Iowa, 미국, 52242
- University of Iowa Hospitals & Clinics
-
-
Louisiana
-
New Orleans, Louisiana, 미국, 70121
- Ochsner Medical Center
-
-
Maryland
-
Baltimore, Maryland, 미국, 21287
- Johns Hopkins
-
-
Massachusetts
-
Boston, Massachusetts, 미국, 02114
- Massachusetts General Hospital
-
-
Michigan
-
Ann Arbor, Michigan, 미국, 48109
- University of Michigan
-
Detroit, Michigan, 미국, 48202
- Henry Ford Hospital
-
Royal Oak, Michigan, 미국, 48073
- William Beaumont Hospital - Royal Oak
-
Saginaw, Michigan, 미국, 48601
- St. Mary's of Ascension Research
-
-
Minnesota
-
Maplewood, Minnesota, 미국, 55109
- Fairview Health Services
-
Rochester, Minnesota, 미국, 55905
- Mayo Clinic
-
-
Missouri
-
Kansas City, Missouri, 미국, 64111
- Saint Luke's Hospital of Kansas City
-
St Louis, Missouri, 미국, 63110
- Washington University School of Medicine
-
-
Montana
-
Missoula, Montana, 미국, 59802
- Providence St. Patrick Hospital
-
-
New Hampshire
-
Lebanon, New Hampshire, 미국, 03756
- Dartmouth-Hitchcock Medical Center
-
-
New Jersey
-
Camden, New Jersey, 미국, 09103
- Cooper Health Systems
-
Morristown, New Jersey, 미국, 07962
- Morristown Medical Center
-
New Brunswick, New Jersey, 미국, 08901
- Rutgers Robert Wood Johnson Medical School
-
-
New York
-
Buffalo, New York, 미국, 14203
- State University of New York at Buffalo
-
New York, New York, 미국, 10065
- Weill Cornell Medicine
-
New York, New York, 미국, 10032
- Columbia University Irving Medical Center/NYPH
-
New York, New York, 미국, 10075
- Lenox Hill Hospital, Northwell Health /Northshore University Hospital Manhasset
-
Rochester, New York, 미국, 14621
- Rochester General Hospital
-
Roslyn, New York, 미국, 11576
- St. Francis Hospital
-
The Bronx, New York, 미국, 10467
- Montefiore Medical Center / Arts Pavilion / Hutchinson Metro Center Clinic / Weiler Hospital / Moses Hospital
-
-
North Carolina
-
Chapel Hill, North Carolina, 미국, 27517
- University of North Carolina
-
-
North Dakota
-
Fargo, North Dakota, 미국, 58104
- Sanford Medical Center Fargo
-
-
Ohio
-
Cincinnati, Ohio, 미국, 45219
- The Christ Hospital
-
Cincinnati, Ohio, 미국, 45242
- TriHealth-Bethesda North Hospital
-
Columbus, Ohio, 미국, 43210
- The Ohio State University
-
-
Oklahoma
-
Oklahoma City, Oklahoma, 미국, 73112
- Integris Baptist Medical Center
-
Oklahoma City, Oklahoma, 미국, 73120
- Oklahoma Cardiovascular Research Group
-
Tulsa, Oklahoma, 미국, 74104
- Oklahoma Heart Institute at Hillcrest Medical Center
-
-
Oregon
-
Portland, Oregon, 미국, 97239
- Oregon Health & Science University
-
-
Pennsylvania
-
Hershey, Pennsylvania, 미국, 17033
- Penn State Hershey
-
Philadelphia, Pennsylvania, 미국, 19104
- Pennsylvania Presbyterian Medical Center / Hospital of the University of Pennsylvania
-
Wormleysburg, Pennsylvania, 미국, 17043
- Pinnacle Health Cardiovascular Institute/UPMC Pinnacle
-
Wynnewood, Pennsylvania, 미국, 19096
- Lankenau Heart Institute
-
-
South Carolina
-
Charleston, South Carolina, 미국, 29245
- Medical University of South Carolina
-
-
Tennessee
-
Chattanooga, Tennessee, 미국, 37403
- Erlanger Health System
-
Nashville, Tennessee, 미국, 37212
- Vanderbilt University Medical Center
-
-
Texas
-
Houston, Texas, 미국, 77030
- The University of Texas Health Science Center at Houston
-
Houston, Texas, 미국, 77004
- HCA Houston Healthcare Medical Center
-
Houston, Texas, 미국, 77030
- Baylor College of Medicine St. Luke's Medical Center
-
Houston, Texas, 미국, 77030
- UTHealth/Memorial Hermann Hospital
-
Plano, Texas, 미국, 75093
- Baylor Scott & White - The Heart Hospital - Plano
-
-
Utah
-
Murray, Utah, 미국, 84107
- Intermountain Medical Center
-
St. George, Utah, 미국, 84790
- St. George Regional Hospital
-
-
Virginia
-
Charlottesville, Virginia, 미국, 22908
- University of Virginia Health System
-
Richmond, Virginia, 미국, 23298
- Virginia Commonwealth University
-
Roanoke, Virginia, 미국, 24014
- Carilion Medical Center
-
-
Washington
-
Seattle, Washington, 미국, 98101
- Virginia Mason Medical Center
-
Seattle, Washington, 미국, 98122
- Swedish Medical Center
-
-
Wisconsin
-
Milwaukee, Wisconsin, 미국, 53226
- Medical College of Wisconsin
-
-
-
-
British Columbia
-
Vancouver, British Columbia, 캐나다, V6Z 1Y6
- St. Paul's Hospital
-
-
Ontario
-
Hamilton, Ontario, 캐나다, L8L 2X2
- Hamilton Health Services
-
Ottawa, Ontario, 캐나다, K1Y 4Q7
- University of Ottawa Heart Institute
-
Toronto, Ontario, 캐나다, M4N 3M5
- Sunnybrook Health Sciences Centre
-
Toronto, Ontario, 캐나다, M5B 1W8
- St. Michael's Hospital
-
-
Quebec
-
Québec, Quebec, 캐나다, G1V 4G5
- Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Eighteen (18) years of age or older
- Despite medical therapy, per the local Heart Team, patient has signs of TR, symptoms from TR, or prior heart failure hospitalization from TR.
- Severe or greater tricuspid regurgitation
- New York Heart Association (NYHA) Class II-IVa or heart failure hospitalization in the prior 12 months
- Patient is at an intermediate or greater estimated risk of mortality with tricuspid valve surgery as determined by the cardiac surgeon with concurrence by the local Heart Team
- Patient is able and willing to give informed consent, follow protocol procedures, and comply with follow-up visit requirements
Exclusion Criteria:
-
Tricuspid valve anatomy not evaluable by TTE or TEE
-
Tricuspid valve anatomy precludes proper device deployment and function
-
Patient with refractory heart failure requiring, advanced intervention (i.e. patient has or will need left ventricular assist device, or transplantation) (ACC/AHA Stage D heart failure)
-
Presence of trans-tricuspid pacemaker or defibrillator leads which meet one of the following:
- Would prevent proper TR reduction due to interaction of the lead with the leaflets
- Were implanted in the RV within the last 90 days prior to the point of enrollment
-
Primary non-degenerative tricuspid disease
-
Previous tricuspid valve repair or replacement that would interfere with placement of PASCAL
-
Clinically significant, untreated coronary artery disease requiring revascularization, unstable angina, evidence of acute coronary syndrome, recent myocardial infarction
-
Significant intra-cardiac mass, thrombus, or vegetation per echo core lab assessment
-
Deep vein thrombosis (DVT) or pulmonary embolism (PE) in the last 90 days
-
Recent Stroke
-
Active gastrointestinal (GI) bleeding
-
Presence of infiltrative cardiomyopathy or valvulopathy (including carcinoid, amyloidosis, sarcoidosis, hemochromatosis) or significant congenital heart disease, including but not limited to atrial septal defect, RV dysplasia, and arrhythmogenic RV
-
Need for emergent or urgent surgery for any reason, any planned cardiac surgery within the next 12 months (365 days), or any planned percutaneous cardiac procedure within the next 90 days
-
Any of the following cardiovascular procedures:
- Percutaneous coronary, intracardiac, or endovascular intervention within the last 30 days prior to the point of enrollment
- Carotid surgery within 30 days prior to the point of enrollment
- Direct current cardioversion within the last 30 days prior to the point of enrollment
- Leadless RV pacemaker implant within the last 30 days prior to the point of enrollment
- Cardiac surgery within 90 days prior to the point of enrollment
-
Severe aortic, mitral and/or pulmonic valve stenosis and/or regurgitation
-
Known history of untreated severe symptomatic carotid stenosis or asymptomatic carotid stenosis
-
Active endocarditis within the last 90 days or infection requiring antibiotic therapy within the last 14 days
-
Patient is oxygen-dependent or requires continuous home oxygen
-
Pregnant, breastfeeding, or planning pregnancy within the next 12 months (365 days)
-
Concurrent medical condition with a life expectancy of less than 12 months in the judgment of the Investigator
-
Patient is currently participating in another investigational biologic, drug, or device clinical study
-
Patient has other medical, social, or psychological conditions that preclude appropriate consent and follow-up, or the patient is under guardianship
-
Any patient considered to be vulnerable
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: Edwards PASCAL System & OMT
Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation |
Transcatheter tricuspid valve repair with the Edwards PASCAL System in patients on optimal medical therapy
다른 이름들:
Transcatheter tricuspid valve repair with the Edwards PASCAL System in conjunction with OMT Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation |
|
활성 비교기: Optimal Medical Therapy (OMT)
Optimal medical therapy (OMT) alone in patients with tricuspid regurgitation |
Optimal Medical Therapy alone in patients with tricuspid regurgitation |
|
실험적: Single-Arm Registry
Transcatheter tricuspid valve repair with the Edwards PASCAL System in conjunction with optimal medical therapy (OMT) in patients with tricuspid regurgitation who are not eligible for randomization |
Transcatheter tricuspid valve repair with the Edwards PASCAL System in patients on optimal medical therapy
다른 이름들:
Transcatheter tricuspid valve repair with the Edwards PASCAL System in conjunction with OMT Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation |
|
실험적: Continued Access Study
Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation |
Transcatheter tricuspid valve repair with the Edwards PASCAL System in patients on optimal medical therapy
다른 이름들:
Transcatheter tricuspid valve repair with the Edwards PASCAL System in conjunction with OMT Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Composite endpoint including all-cause mortality, RVAD implantation or heart transplant, tricuspid valve intervention, heart failure hospitalizations, and Quality of Life improvement (measured by KCCQ score)
기간: 6 months
|
Comparison of number of participants with composite endpoint events between experimental and active comparator arms |
6 months
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
1 Grade Reduction in TR Severity
기간: 6, 12 months
|
Total number of participants with at least 1 grade reduction in TR severity |
6, 12 months
|
|
Quality of Life (QOL) as Measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ)
기간: 3, 6, and 12 months
|
Change in KCCQ score from baseline |
3, 6, and 12 months
|
|
All Cause Mortality
기간: 12 months, 24 months
|
Total number of deaths from any cause |
12 months, 24 months
|
|
Death and Heart Failure Hospitalizations
기간: 12 months
|
Total number of deaths and hospital admissions due to heart failure |
12 months
|
|
All-cause Mortality, TV Surgery or TV Interventions
기간: 24 months
|
Total number of deaths, TV surgeries or interventions |
24 months
|
|
Right ventricular end-diastolic diameter (RVEDD mid)
기간: 12 months
|
Change in right ventricular end-diastolic diameter (RVEDD mid) |
12 months
|
|
Major Adverse Events (MAEs)
기간: 30 days
|
Overall rate of Major Adverse Events (MAEs) |
30 days
|
|
Reduction in TR grade
기간: Intraprocedural post-implantation
|
Reduction in TR severity as assessed by TEE pre- and post-implantation |
Intraprocedural post-implantation
|
|
All-Cause Mortality
기간: 12 months, annually through 5 years
|
Total number of deaths from any cause |
12 months, annually through 5 years
|
|
Heart failure hospitalizations
기간: 12 months, annually through 5 years
|
Total number of hospital admissions due to heart failure |
12 months, annually through 5 years
|
|
Non-elective tricuspid valve re-intervenitions (percutaneous or surgical)
기간: 12 months, annually through 5 years
|
Total number of non-elective tricuspid valve re-interventions |
12 months, annually through 5 years
|
|
Durable RVAD implantation or heart transplant
기간: 12 months, annually through 5 years
|
Total number of patients requiring RVAD impantantion or heart transplant |
12 months, annually through 5 years
|
|
Need for paracentesis
기간: 12 months, annually through 5 years
|
Total nunber of patients who required paracentesis |
12 months, annually through 5 years
|
|
All cause mortality or the first heart failure hospitalization for patients with massive or torrential TR at baseline
기간: 12, 24 months
|
Time to death or first heart failure hospitalization |
12, 24 months
|
|
All-cause Hospitalizations
기간: 12 months
|
Number of hospitalizations for any cause |
12 months
|
공동 작업자 및 조사자
수사관
수사관
- 수석 연구원: Martin B. Leon, MD, Columbia University
- 수석 연구원: Michael J. Mack, MD, Baylor Scott and White Health
- 연구 의자: Gorav Ailawadi, MD, University of Michigan
- 수석 연구원: Charles Davidson, MD, Northwestern University
- 연구 의자: Allen Anderson, MD, The University of Texas Health Science Center at San Antonio
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
기타 연구 ID 번호
- 2019-07
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .